Huijgens PC - Search Results

1

Development of white blood cell fragments, during the preparation and storage of platelet concentrates, as measured by using real-time polymerase chain reaction.

Dijkstra-Tiekstra MJ, van der Schoot CE, Pietersz RN, Huijgens PC, van der Meer PF, Reesink HW. Dijkstra-Tiekstra MJ, et al. Among authors: huijgens pc. Vox Sang. 2004 Nov;87(4):250-6. doi: 10.1111/j.1423-0410.2004.00576.x. Vox Sang. 2004. PMID: 15585020

2

In vivo PLT increments after transfusions of WBC-reduced PLT concentrates stored for up to 7 days.

Dijkstra-Tiekstra MJ, Pietersz RN, Hendriks EC, Reesink HW, Huijgens PC. Dijkstra-Tiekstra MJ, et al. Among authors: huijgens pc. Transfusion. 2004 Mar;44(3):330-6. doi: 10.1111/j.1537-2995.2003.00622.x. Transfusion. 2004. PMID: 14996188

3

Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters.

Dijkstra-Tiekstra MJ, Pietersz RN, Huijgens PC. Dijkstra-Tiekstra MJ, et al. Among authors: huijgens pc. Vox Sang. 2004 Nov;87(4):257-63. doi: 10.1111/j.1423-0410.2004.00573.x. Vox Sang. 2004. PMID: 15585021 Clinical Trial.

4

Preparation of leucocyte-poor platelet concentrates from buffy coats. IV. Clinical evaluation.

Pietersz RN, Reesink HW, Huijgens PC, van Oers MH. Pietersz RN, et al. Among authors: huijgens pc. Vox Sang. 1988;55(3):129-32. doi: 10.1111/j.1423-0410.1988.tb05078.x. Vox Sang. 1988. PMID: 3070936 Clinical Trial.

5

WBC-reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures.

van der Meer PF, Pietersz RN, Tiekstra MJ, Huijgens PC, Dekker WJ, Reesink HW. van der Meer PF, et al. Among authors: huijgens pc. Transfusion. 2001 Jul;41(7):917-22. doi: 10.1046/j.1537-2995.2001.41070917.x. Transfusion. 2001. PMID: 11452160

6

Effect of pre-incubation at 37 degrees C of platelet concentrates on the post-transfusion platelet adhesion capacity to collagen and fibrinogen.

Boomgaard MN, Stulp JG, de Korte D, Pietersz RN, Reesink HW, Huijgens PC, Loos JA. Boomgaard MN, et al. Among authors: huijgens pc. Haemostasis. 1993 Nov-Dec;23(6):327-34. doi: 10.1159/000216896. Haemostasis. 1993. PMID: 8034239 Clinical Trial.

7

Beneficial effect of pre-transfusion warming of platelets prepared from buffy coats.

Fijnheer R, Pietersz RN, Huijgens PC, de Korte D, Roos D, Reesink HW. Fijnheer R, et al. Among authors: huijgens pc. Lancet. 1990 Jun 23;335(8704):1524. doi: 10.1016/0140-6736(90)93060-3. Lancet. 1990. PMID: 1972448 No abstract available.

8

[Are there still indications for plasma transfusions?].

Huijgens PC, Ossenkoppele GJ, Pietersz RN, Reesink HW. Huijgens PC, et al. Ned Tijdschr Geneeskd. 1991 Dec 14;135(50):2401-2. Ned Tijdschr Geneeskd. 1991. PMID: 1749448 Dutch. No abstract available.

9

High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome.

Feller N, Schuurhuis GJ, van der Pol MA, Westra G, Weijers GW, van Stijn A, Huijgens PC, Ossenkoppele GJ. Feller N, et al. Among authors: huijgens pc. Leukemia. 2003 Jan;17(1):68-75. doi: 10.1038/sj.leu.2402781. Leukemia. 2003. PMID: 12529662 Clinical Trial.

10

A single-step colony-forming unit assay for unseparated mobilized peripheral blood, cord blood, and bone marrow.

de Kreuk AM, Zevenbergen A, van Oostveen JW, Schuurhuis GJ, Huijgens PC, Jonkhoff AR. de Kreuk AM, et al. Among authors: huijgens pc. J Hematother Stem Cell Res. 2001 Dec;10(6):795-806. doi: 10.1089/152581601317210890. J Hematother Stem Cell Res. 2001. PMID: 11798506

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page